White label ELPA - ClinicalTrials.eu

Study on the Effectiveness and Safety of Ocrelizumab for Patients with Progressive Multiple Sclerosis

Not recruiting

3 1 1 1
Investigated diseases:
- Multiple sclerosis
- Progressive multiple sclerosis
Investigated drugs:
+1
Study on the Effectiveness and Safety of Infigratinib for Children Aged 3 to 17 with Achondroplasia

Not recruiting

3 1
Investigated diseases:
- Osteochondrodysplasia
Investigated drugs:
- Infigratinib
Study on the Effects of Zibotentan and Dapagliflozin in Patients with Chronic Kidney Disease and High Protein Levels

Not recruiting

3 1 1 1
Investigated diseases:
- Chronic kidney disease
Investigated drugs:
- Zibotentan
- Dapagliflozin
+6
Study on Methoxyflurane for Pain Relief in Adult Dental Emergencies

Not recruiting

3 1 1
Investigated drugs:
- Methoxyflurane
Study on Rivaroxaban for Patients with Atrial Fibrillation and Coronary Artery Disease After Heart Procedure

Not recruiting

3 1 1 1
Investigated diseases:
- Atrial fibrillation
- Coronary artery disease
Investigated drugs:
- Rivaroxaban
Study on Finerenone for Children with Chronic Kidney Disease and Proteinuria Using ACEI or ARB

Not recruiting

3 1
Investigated diseases:
- Chronic kidney disease
- Proteinuria
Investigated drugs:
- Finerenone
+11
Study on the Safety and Effectiveness of Upadacitinib for Adults and Adolescents with Severe Alopecia Areata

Not recruiting

3 1
Investigated diseases:
- Alopecia areata
Investigated drugs:
- Upadacitinib
+7
Study on the Safety and Effectiveness of Adding Hydroxycarbamide to Standard Treatment with Cytarabine and Daunorubicin for Adults with Newly Diagnosed Acute Myeloid Leukemia

Not recruiting

1 1 1 1
Investigated diseases:
- Acute myeloid leukaemia
Investigated drugs:
Study on the Safety and Effects of IMG-007 for Adults with Moderate to Severe Atopic Dermatitis

Not recruiting

1 1 1
Investigated diseases:
- Dermatitis atopic
Investigated drugs:
- Img-007
Study of Imetelstat Compared to Drug Combination for Treating Intermediate-2 or High-Risk Myelofibrosis in Patients Not Responding to JAK-Inhibitor Treatment

Not recruiting

3 1 1 1
Investigated diseases:
- Myelofibrosis
Investigated drugs:
+5

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies